Table 1 Baseline characteristics of the participants.

From: Predictive value of heart rate deceleration capacity on coronary artery lesion in acute phase of Kawasaki disease

Parameter

control group

AURI group

KD-NCAL group

KD-CAL group

F/χ2

P

(n = 100)

(n = 30)

(n = 130)

(n = 50)

Age (months)

31 (20~40)

30 (17~45)

33 (20~43)

28 (18~38)

4.101

0.250

Gender male

65

16

80

30

1.410

0.703

             female

35

14

50

20

  

DC(ms)

6.06 (5.23~6.69)

5.43 (4.76~6.23)a

5.47 (4.77~5.95)a

3.70 (2.68~5.37)a, b, c

60.027

<0.001

PNN50(%)

16 (8~28)

10 (5~19)a

9 (2~16)a

3 (0~10)a, b, c

56.470

<0.001

rMSSD(ms)

45 (33~58)

42 (30~55)

37 (29~45)a

32 (26~42)a, b

21.507

<0.001

HF(ms2)

393.7(226.1~572.6)

146.4 (82.5~229.9)a

118.5 (54.1~202.0)a

70.3 (40.7~190.7)a, b

123.624

<0.001

NT-proBNP (pg/ml)

—

105 (74~120)

398 (118~819)b

867 (709~987)b, c

65.583

<0.001

CRP (mg/dl)

—

1.5 (0.9~1.9)

3.9 (2.8~5.1)b

6.3 (3.9~12.7)b, c

88.325

<0.001

  1. Data are presented as medians (interquartile ranges).
  2. aP < 0.05, compared with the control group; bP < 0.05, compared with the AURI group; cP < 0.05, compared with the KD-NCAL group; —, this data was not detected; AURI, acute upper respiratory infection; KD, kawasaki disease; CAL, coronary artery lesion; KD-CAL, KD with CAL group; KD-NCAL group, KD without CAL group; DC, heart rate deceleration capacity; PNN50, percentage of successive normal sinus RR intervals >50 ms; HF, high frequency; rMSSD, root mean squared successive difference; NT-proBNP, N-terminal pro-brain natriuretic peptide; CRP, C-reactive protein.